Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Extension Study of Trastuzuma Emtansine in Patients Previously Treated With Trastuzuma Emtansine

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Genentech, Inc.
ClinicalTrials.gov Identifier:
NCT00781612
First received: October 27, 2008
Last updated: November 1, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: September 2022
  Estimated Primary Completion Date: September 2022 (Final data collection date for primary outcome measure)